Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature

Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature

Several guidelines endorsed the indefinite use warfarin or heparin-containing products for acute venous thromboembolism (VTE) treatment and secondary prevention and discouraged the use of direct oral anticoagulants (DOAC) for patients diagnosed with antiphospholipid syndrome (APS). However, adequate...

Full description

Bibliographic Details
Main Authors: Khalid Al Sulaiman SCC-CCP, BCCCP, BCNSP, MBA, Awatif Hafiz PharmD, BCCP, Hisham A. Badreldin PharmD, FCCP, BCPS, BCCP, Ghazwa B. Korayem PharmD, BCPS, Faisal Alsuwayyid PharmD, Abdulrahman Alrashidi, PharmD, Mohammed Alhijris PharmD, Faisal Almutairi, PharmD, Fahad Alharthi PharmD, Saad Alghamdi PharmD, Ahmed Abu Alreesh ClinPharmM.Sc, Ohoud Aljuhani PharmD, BCCCP
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096221099893

Internet

https://doi.org/10.1177/23247096221099893

Similar Items